Skip to main content

Table 1 MRI data for negative cases in hepatobiliary phase

From: Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?

 

Negative cases / mean (±SD)

Positive cases/mean (±SD)

p values

case#1

case#2

case#3

case#4

case#5

case#6

case#7

case#8

Visible in hepatobiliary phase

0/8

59/59

 

0

0

0

0

0

0

0

0

Visible in T1w

7/8

54/59

 

1

1

1

1

1

1

1

0

Visible in t2w

7/8

49/59

 

1

1

0

1

1

1

1

1

Visible in DWI

6/8

50/59

 

1

1

0

0

1

1

1

1

Wash-in visible

4/8

53/59

 

1

0

0

0

0

1

1

1

Wash-out visible

0/8

47/59

 

0

0

0

0

0

0

0

0

Size in cm

3.28(±1.70)

5.43(±4.25)

n.s.

1.50

5.00

3.50

2.20

1.00

2.90

6.50

3.60

T1 RIR

1.17(±0.21)

0.82(±0.23)

0.0002

1.31

1.20

1.31

1.11

1.00

1.55

1.04

0.82

T2 fs RIR

1.30(±0.45)

1.95(±0.94)

n.s.

1.71

1.28

0.76

0.89

0.74

1.26

1.72

2.00

ADC

0.87(±0.14)

0.89(±0.29)

n.s.

0.87

0.52

0.95

0.88

0.92

0.98

0.87

0.95

ERa

50.13(±26.58)

84.30(±38.59)

0.0198

75.97

11.52

11.69

65.88

33.67

84.62

67.68

50.00

ER late

44.68(±25.99)

57.27(±33.13)

n.s.

39.86

8.76

5.66

54.71

41.71

90.23

60.95

55.56

RIR HB

1.00(±0.19)

0.65(±0.23)

0.0001

1.08

0.98

0.68

1.02

0.99

1.42

0.94

0.92

  1. Hepatobiliary negative cases are shown in column 1 in comparison to hepatobiliary positive cases in column 2. Individual values for negative cases#1–8 are shown on the right. Quantitative values are given as mean ± standard deviation (SD). P values are given for group comparison. RIR relative enhancement ratio. ADC apparent diffusion coefficient. ER enhancement ratio